Press Releases Archives - Page 83 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Consistent Growth, Robust Profits Quarter II Results, FY 2013-14 Net Sales up 18%; EBITDA up 42%; Net profit up 40%

October 30, 2012

Lupin launches Generic Seasonale® Tablets; receives FDA approval

October 25, 2012

Record Sales & Profits Quarter II Results, FY 2012-13 Net Sales up 29%, EBITDA up 28%, PBT up 27%, PAT up 9%

October 23, 2012

Lupin Receives FDA Approval for its New Drug Application for Antara® Capsules

October 22, 2012

Lupin receives FDA approval for its Oral Contraceptive Kurvelo® Tablets; The Generic of Nordette® Tablets

October 18, 2012

Lupin receives FDA approval for Generic Avapro® Tablets

October 17, 2012

Lupin receives FDA approval for its Oral Contraceptive VyfemlaTM Tablets Generic of Ovcon® 35 Tablets

September 27, 2012

Lupin receives FDA approval for Generic Lexapro® Tablets e® Tablets

September 13, 2012

Record Sales & Profits Net Sales up 44%, PBT up 67%, PAT up 33% Quarter I Results, FY 2012-13

Ernst & Young announces Lupin Pharmaceuticals Inc., CEO Vinita Gupta as Entrepreneur of the Year, Maryland – 060712

1 2 … 82 83 84 … 102 103

Search

Hit enter to search or ESC to close